Comparison between Mankind Pharma IPO and Nexus Select Trust REIT.
Mankind Pharma IPO is a Mainboard Bookbuilding IPO proposed to list at BSE, NSE while Nexus Select Trust REIT is a Mainboard Bookbuilding proposed to list at BSE, NSE.
The total issue size of Mankind Pharma IPO is up to ₹4,326.36 Cr whereas the issue size of the Nexus Select Trust REIT is up to ₹3,200.00 Cr. The final issue price of Mankind Pharma IPO is ₹1,080.00 per share and of Nexus Select Trust REIT is ₹100.00 per share.
| Mankind Pharma IPO | Nexus Select Trust REIT | |
|---|---|---|
| Face Value | ₹1 per share | |
| Issue Price (Lower) | ₹1,026.00 per share | ₹95.00 per share |
| Issue Price (Upper) | ₹1,080.00 per share | ₹100.00 per share |
| Issue Price (Final) | ₹1,080.00 per share | ₹100.00 per share |
| Discount (Retail) | ₹0.00 per share | |
| Discount (Employee) | ||
| Market Lot Size | 13 shares | 150 shares |
| Fresh Issue Size | 0 shares | 14,00,00,000 shares |
| Fresh Issue Size (Amount) | up to ₹0.00 Cr | up to ₹1,400.00 Cr |
| OFS Issue Size | 4,00,58,844 shares | 18,00,00,000 shares |
| OFS Issue Size (Amount) | up to ₹4,326.36 Cr | up to ₹1,800.00 Cr |
| Issue Size Total | 4,00,58,844 shares | 32,00,00,000 shares |
| Issue Size Total (Amount) | up to ₹4,326.36 Cr | up to ₹3,200.00 Cr |
Mankind Pharma IPO opens on Apr 25, 2023, while Nexus Select Trust REIT opens on May 09, 2023. The closing date of Mankind Pharma IPO and Nexus Select Trust REIT is Apr 27, 2023, and May 11, 2023, respectively.
| Mankind Pharma IPO | Nexus Select Trust REIT | |
|---|---|---|
| Anchor Bid Date | Apr 24, 2023 | May 08, 2023 |
| Issue Open | Apr 25, 2023 | May 09, 2023 |
| Issue Close | Apr 27, 2023 | May 11, 2023 |
| Basis Of Allotment (Tentative) | May 03, 2023 | May 16, 2023 |
| Initiation of Refunds (Tentative) | May 04, 2023 | May 17, 2023 |
| Credit of Share (Tentative) | May 05, 2023 | May 18, 2023 |
| Listing date (Tentative) | May 09, 2023 | May 19, 2023 |
| Anchor Lockin End date 1 | Jun 02, 2023 | Jun 15, 2023 |
| Anchor Lockin End date 2 | Aug 01, 2023 | Aug 14, 2023 |
Mankind Pharma IPO P/E ratio is 32.5, as compared to Nexus Select Trust REIT P/E ratio of .
| Mankind Pharma IPO | Nexus Select Trust REIT | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financials | Company Financials (Restated Consolidated)
| Company Financials (Restated Consolidated)
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Pre-Issue) | 79.00 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Post-Issue) | 76.50 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| P/E Ratio | 32.5 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Market Cap | ₹43263.60 Cr. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROE | 27.60% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROCE | 26.10% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Debt/Equity | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EPS | ₹33.20 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| RoNW | 27.70% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
In the Mankind Pharma IPO Retail Individual Investors (RII) are offered 1,40,20,596 shares while in Nexus Select Trust REIT retail investors are offered 1,40,20,596 shares. Qualified Institutional Buyers (QIB) are offered 80,11,769 shares in Mankind Pharma IPO and 9,60,00,150 shares in Nexus Select Trust REIT.
| Mankind Pharma IPO | Nexus Select Trust REIT | |
|---|---|---|
| Anchor Investor Reservation | 1,20,17,652 shares | 14,39,99,850 shares |
| Market Maker Reservation | 0 shares | |
| QIB | 80,11,769 shares | 9,60,00,150 shares |
| NII | 60,08,827 shares | 8,00,00,000 shares |
| RII | 1,40,20,596 shares | 0 shares |
| Employee | 0 shares | |
| Others | ||
| Total | 4,00,58,844 shares | 32,00,00,000 shares |
Mankind Pharma IPO subscribed 15.32x in total, whereas Nexus Select Trust REIT subscribed 5.45x.
| Mankind Pharma IPO | Nexus Select Trust REIT | |
|---|---|---|
| QIB (times) | 49.16x | 4.81x |
| NII (times) | 3.80x | |
| Big NII (times) | 4.99x | |
| Small NII (times) | 1.41x | |
| RII (times) | 0.92x | |
| Employee (times) | ||
| Other (times) | 6.23x | |
| Total (times) | 15.32x | 5.45x |
